Hearing for Learning Initiative - a Health Facilitator Model for Otitis Media (HfLI)

March 12, 2024 updated by: Menzies School of Health Research

The Hearing for Learning Initiative - a Service-enhancement Model of Ear Health Facilitators to Address the Crisis in Ear and Hearing Health of Aboriginal Children in the Northern Territory: a Stepped-wedge Cluster Randomised Trial

The Hearing for Learning Initiative is a stepped-wedge cluster randomised controlled trial. The HfLI will implement and rigorously evaluate an innovative community-based service-enhancement model of ear and hearing health, in partnership with participating communities and health and education services.

This initiative will address the following research question: In urban, rural and remote Aboriginal communities in the Northern Territory, does employment, training and integration of local Ear and Hearing Clinical and Education Support Officers into health and education services (the Hearing for Learning initiative), compared to current practice, increase the proportion of children who receive an ear assessment, reduce the prevalence of ear and hearing problems and improve education outcomes of Aboriginal and Torres Strait Islander children, during a four year trial period?

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

Background: Australian Indigenous children achieve lower scores in school readiness and education outcomes than their non-Indigenous peers. Chronic otitis media and hearing loss during early childhood are associated with lower scores for these outcomes. Local problem: Failure to meet child health program schedules and evidence based practice in ear and hearing health is linked to high turnover of the health workforce, inadequate clinical skills and poor knowledge of ear and hearing health needs of children.

This Hearing for Learning Initiative aims to improve health care and education services.

Interventions: The intervention involves training and employing non-professional community members to facilitate busy primary health care services to deliver evidence-based ear and hearing health assessments in children 0 to 16 years of age, and to facilitate the teaching and home learning of hearing impaired children (the intervention).

Trial design: A stepped-wedge community (n=18) cluster-randomised trial will compare the proportion of children receiving an ear assessment (primary outcomes) in the HfLI (intervention) periods with no HfLI (control) periods. Participating communities will be randomly assigned in 6-monthly steps to shift from control to intervention on pre-specified start dates.

Outcomes: the primary outcome is the change in the proportion of Aboriginal and Torres Strait Islander children who receive an ear assessment, between intervention and control periods.

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Northern Territory
      • Ali Curung, Northern Territory, Australia
        • Ali Curung
      • Ampilatwatja, Northern Territory, Australia
        • Ampilatwatja
      • Darwin, Northern Territory, Australia, 0800
        • Darwin
      • Galiwin'ku, Northern Territory, Australia
        • Galiwin'ku
      • Gunbalanya, Northern Territory, Australia
        • Gunbalanya
      • Kalkarindji, Northern Territory, Australia, 0852
        • Kalkarindji Primary Health Centre
      • Katherine, Northern Territory, Australia, 0850
        • Wurli Wurlinjang Health Service
      • Lajamanu, Northern Territory, Australia
        • Lajamanu Primary Health Centre
      • Maningrida, Northern Territory, Australia, 0820
        • Mala'la Health Service
      • Milikapiti, Northern Territory, Australia
        • Milikapiti Community Health Centre
      • Milingimbi, Northern Territory, Australia, 0822
        • Milingimbi Health Clinic
      • Minjilang, Northern Territory, Australia
        • Minjilang Community Health Centre
      • Nauiyu, Northern Territory, Australia
        • Nauiyu
      • Palumpa, Northern Territory, Australia, 0822
        • Palumpa Community Health Centre
      • Pirlangimpi, Northern Territory, Australia, 0822
        • Pirlangimpi Health Clinic
      • Ti Tree, Northern Territory, Australia, 0872
        • Ti Tree Community Health Centre
      • Wadeye, Northern Territory, Australia, 0822
        • Wadeye Community Health Centre
      • Warruwi, Northern Territory, Australia, 0822
        • Warruwi Community Health Centre
      • Wurrumiyanga, Northern Territory, Australia, 0822
        • Julanimawu (Nguiu) Community Health centre
      • Yirrkala, Northern Territory, Australia, 0880
        • Yirrkala Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 week to 16 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria: Aboriginal or Torres Strait Islander, resident in participating community (cluster)

Exclusion Criteria: none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Facilitator
120 hours training for local community members delivered on-country face-to-face during 6 4-day weeks and over a 3-6 month period. Certificate II modules in Aboriginal Primary Health Care, ear and hearing health skills development (otoscopy, tympanometry, and hearScreen) and employment as Ear Health Facilitators to the end of the trial.
Training and employment of community members to assist the diagnosis and management of otitis media
No Intervention: Control
No Facilitator. Brief 6-monthly 2 to 3 hour in-service training via zoom for health professionals.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ear assessment
Time Frame: 6-monthly
Proportion of children who have had a documented ear assessment
6-monthly

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of otitis media
Time Frame: 6-monthly
Proportion of children with any otitis media
6-monthly
Management plan
Time Frame: 6-monthly
Proportion of otitis media cases with a management plan
6-monthly
Appropriate management plan
Time Frame: 6-monthly
Proportion of management plans that are appropriate
6-monthly
Follow-up
Time Frame: 6-monthly
Proportion of cases with follow-up within 10 days
6-monthly

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of hearing loss among school age children
Time Frame: 6-monthly
Proportion of school age children with conductive hearing loss
6-monthly

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amanda Leach, PhD, Menzies School of Health Research
  • Study Director: Kelvin Kong, MBBS, Newcastle University
  • Study Director: Peter S Morris, MBBS, PhD, Menzies School of Health Research
  • Study Director: Alan Cass, MBBS, PhD, Menzies School of Health Research

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 3, 2019

Primary Completion (Estimated)

June 30, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

April 12, 2019

First Submitted That Met QC Criteria

April 12, 2019

First Posted (Actual)

April 16, 2019

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 12, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • R813
  • TEHREC -18-3264 (Other Identifier: Ethics Committee)
  • CAHREC - 19-330 (Other Identifier: Ethics Committee)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Otitis Media

Clinical Trials on facilitator

3
Subscribe